Industry News

      TYME Technologies, Inc. Provides Update on Precision Promise Trial in Metastatic Pancreatic Cancer

      BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced the discontinuation...

      Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

      BOSTON & PALO ALTO, Calif.--(BUSINESS WIRE)--Akili Interactive (“Akili” or the “Company”), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered...

      Flatiron Health Announces RWD Partnership With Japan’s NCCHE

      NEW YORK--(BUSINESS WIRE)--Flatiron HealthⓇ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with...

      Prospection and Novotech Partner To Accelerate Clinical Trials With Real World Evidence

      SYDNEY--(BUSINESS WIRE)--Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce a strategic partnership to combine the power...

      Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session

      WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, announced the...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.